瑞普生物

- 300119

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
瑞普生物(300119) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入109,903.8153,319.91224,896.21158,716.4899,409.63
营业收入109,903.8153,319.91224,896.21158,716.4899,409.63
二、营业总成本93,026.4943,586.77187,433.26131,439.7582,388.91
营业成本56,579.4227,872.85113,151.1677,853.7947,738.13
营业税金及附加1,158.74417.992,220.401,514.421,023.98
销售费用18,018.347,128.5337,095.7926,662.1217,638.60
管理费用7,886.854,018.2415,777.7311,556.887,360.38
财务费用1,034.93507.261,893.981,434.16929.23
研发费用8,348.203,641.8917,294.1912,418.387,698.59
资产减值损失----------
公允价值变动收益1,489.181,017.956,125.992,977.672,196.17
投资收益164.363.101,515.062,360.212,139.31
其中:对联营企业和合营企业的投资收益151.82-8.862,135.492,343.252,131.15
汇兑收益----------
三、营业利润18,907.9910,537.5456,523.0232,671.8421,589.03
加:营业外收入103.3636.97295.8748.9411.55
减:营业外支出180.3466.67150.88112.2389.94
其中:非流动资产处置损失----------
四、利润总额18,831.0210,507.8556,668.0132,608.5521,510.63
减:所得税费用2,050.171,157.385,566.333,118.462,163.24
五、净利润16,780.859,350.4751,101.6729,490.1019,347.39
归属于母公司所有者的净利润15,913.948,757.1145,294.2127,369.8017,827.11
少数股东损益866.91593.365,807.472,120.301,520.28
六、每股收益
基本每股收益(元/股)0.34560.19010.97720.59000.3843
稀释每股收益(元/股)0.34560.19010.97720.59000.3843
七、其他综合收益----------
八、综合收益总额16,780.859,350.4751,101.6729,490.1019,347.39
归属于母公司所有者的综合收益总额15,913.948,757.1145,294.2127,369.8017,827.11
归属于少数股东的综合收益总额866.91593.365,807.472,120.301,520.28
下载全部历史数据到excel中 返回页顶